Page 73 - ITPS-8-3
P. 73

INNOSC Theranostics and
            Pharmacological Sciences                            Knowledge, perception, and practices of ecopharmacovigilance



            7.   Daughton CG. Pharmaceuticals and the environment (PiE):      doi: 10.1016/j.scitotenv.2019.134815
               Evolution and impact of the published literature revealed by   18.  Wang  H,  Wang  N,  Wang  B,  et al.  Antibiotics  detected  in
               bibliometric analysis. Sci Total Environ. 2016;562:391-426.
                                                                  urines and adipogenesis in school children.  Environ Int.
               doi: 10.1016/j.scitotenv.2016.03.109               2016;89-90:204-211.
            8.   He BS, Wang J, Liu J, Hu XM. Eco-pharmacovigilance of      doi: 10.1016/j.envint.2016.02.005
               non-steroidal anti-inflammatory drugs:  Necessity and   19.  Chen D, Liu S, Zhang M, Li S, Wang J. Comparison of
               opportunities. Chemosphere. 2017;181:178-189.
                                                                  the occurrence of antibiotic residues in two rural ponds:
               doi: 10.1016/j.chemosphere.2017.04.084             Implication for ecopharmacovigilance.  Environ Monit
            9.   Blair BD. Potential upstream strategies for the mitigation of   Assess. 2018;190(9):539.
               pharmaceuticals in the aquatic environment: A brief review.      doi: 10.1007/s10661-018-6883-0
               Curr Environ Health Rep. 2016;3(2):153-160.
                                                               20.  Van Puyvelde S, Deborggraeve S, Jacobs J. Why the antibiotic
               doi: 10.1007/s40572-016-0088-x                     resistance crisis requires a one health approach. Lancet Infect
            10.  Rodríguez-Navas C, Björklund E, Bak SA, et al. Pollution   Dis. 2018;18(2):132-134.
               pathways of pharmaceutical residues in the aquatic      doi: 10.1016/S1473-3099(17)30704-1
               environment on the Island of Mallorca, Spain. Arch Environ
               Contam Toxicol. 2013;65(1):56-66.               21.  Hernando-Amado S, Coque TM, Baquero F, Martínez JL.
                                                                  Defining and combating antibiotic resistance from one
               doi: 10.1007/s00244-013-9880-x                     health and global health perspectives.  Nat Microbiol.
            11.  Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor  D,   2019;4(9):1432-1442.
               Sörme P. Implementing ecopharmacovigilance in practice:      doi: 10.1038/s41564-019-0503-9
               Challenges and potential opportunities.  Drug Saf.
               2013;36(7):533-546.                             22.  Rocha MJ, Cruzeiro C, Reis M, Pardal MÂ, Rocha E. Pollution
                                                                  by oestrogenic endocrine disruptors and  β-sitosterol in a
               doi: 10.1007/s40264-013-0049-3                     south-western European river (Mira, Portugal).  Environ
            12.  Ashfaq M, Noor N, Saif‐Ur‐Rehman M, et al. Determination   Monit Assess. 2016;188(4):240.
               of commonly used pharmaceuticals in hospital waste of      doi: 10.1007/s10661-016-5236-0
               Pakistan and evaluation of their ecological risk assessment.
               Clean Soil Air Water. 2017;45(6):1500392.       23.  Kvarnryd M, Grabic R, Brandt I, Berg C. Early life progestin
                                                                  exposure causes arrested oocyte development, oviductal
               doi: 10.1002/clen.201500392                        agenesis and sterility in adult Xenopus tropicalis frogs. Aquat
            13.  Helal RM, Abou-ElWafa HS. Self-medication in university   Toxicol. 2011;103(1-2):18-24.
               students from the city of Mansoura, Egypt. J Environ Public      doi: 10.1016/j.aquatox.2011.02.003
               Health. 2017;2017:9145193.
                                                               24.  Qiu  L,  Dong  Z, Sun  H,  Li  H,  Chang  CC.  Emerging
               doi: 10.1155/2017/9145193                          pollutants  -  Part  I: Occurrence,  fate  and transport.  Water
            14.  Angi’enda SA, Bukachi SA. Household knowledge and   Environ Res. 2016;88(10):1855-1875.
               perceptions on disposal practices of unused medicines in      doi: 10.2175/106143016X14696400495811
               Kenya. J Anthropol Archaeol. 2016;4(2):1-20.
                                                               25.  Tiseo K, Huber L, Gilbert M, Robinson TP, Van Boeckel TP.
               doi: 10.15640/jaa.v4n2a1                           Global trends in antimicrobial use in food animals from
            15.  Küster A, Adler N. Pharmaceuticals in the environment:   2017 to 2030. Antibiotics (Basel). 2020;9(12):918.
               Scientific evidence of risks and its regulation. Philos Trans R      doi: 10.3390/antibiotics9120918
               Soc Lond B Biol Sci. 2014;369(1656):20130587.
                                                               26.  Wilkinson JL, Boxall ABA, Kolpin DW, et al. Pharmaceutical
               doi: 10.1098/rstb.2013.0587                        pollution of the world’s rivers.  Proc Natl Acad Sci U S A.
            16.  Gaw S, Thomas KV, Hutchinson TH. Sources, impacts   2022;119(8):e2113947119.
               and trends of pharmaceuticals in the marine and      doi: 10.1073/pnas.2113947119
               coastal environment.  Philos Trans R Soc Lond B Biol Sci.
               2014;369(1656):20130572.                        27.  Silva LJG,  Lino CM,  Meisel  L, Barceló  D, Pena A.
                                                                  Ecopharmacovigilance. In: Barcelo D, editor.  The
               doi: 10.1098/rstb.2013.0572
                                                                  Handbook of Environmental Chemistry. Germany:
            17.  Jose J, Sandra Pinto J, Kotian B, Mathew Thomas A, Narayana   Springer-Verlag Berlin, Heidelberg GmbH & Co. KG;
               Charyulu R. Comparison of the regulatory outline of   2012.  p.  213-242.  Available  from:  https://link.springer.
               ecopharmacovigilance of pharmaceuticals in Europe, USA,   com/chapter/10.1007/698_2011_128 [Last accessed on
               Japan and Australia. Sci Total Environ. 2020;709:134815.  2024 Jul 12].


            Volume 8 Issue 3 (2025)                         67                               doi: 10.36922/itps.7678
   68   69   70   71   72   73   74   75   76   77   78